Page last updated: 2024-10-24

verapamil and Amyloid Angiopathy, Cerebral

verapamil has been researched along with Amyloid Angiopathy, Cerebral in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Assema, DM1
Goos, JD1
van der Flier, WM1
Lubberink, M1
Boellaard, R1
Windhorst, AD1
Scheltens, P1
Lammertsma, AA1
van Berckel, BN1
Crawford, F1
Suo, Z1
Fang, C1
Mullan, M1

Other Studies

2 other studies available for verapamil and Amyloid Angiopathy, Cerebral

ArticleYear
No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:8

    Topics: Aged; Alzheimer Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrie

2012
Characteristics of the in vitro vasoactivity of beta-amyloid peptides.
    Experimental neurology, 1998, Volume: 150, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aorta; Calcimycin; Calcium Channel Blockers; Calc

1998